Who owns DYN?
Institutional ownership of Dyne Therapeutics Inc. from Form 13F, Q2 2026
246 institutional managers reported holding Dyne Therapeutics Inc. (DYN) in Form 13F filings for Q2 2026, with 190,604,522 shares worth $4.2B. The largest reported holder was T. Rowe Price Investment Management, Inc. Managers that filed both quarters added a net 3,929,811 shares (+2.3%). 45 opened new positions and 29 sold out.
- Funds holding
- 246
- Value held
- $4.2B
- New / sold out
- 45 / 29
- Net shares, same filers
- +2.3%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of DYN
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | $687M | 16.2% | 30,912,287 | Added |
| BlackRock, Inc. | $276M | 6.5% | 12,404,330 | Added |
| Jupiter Topco LLC | $267M | 6.3% | 11,997,738 | First report |
| FMR LLC | $249M | 5.9% | 11,207,000 | Added |
| State Street Corp | $166M | 3.9% | 7,458,263 | Added |
| Orbis Allan Gray Ltd | $156M | 3.7% | 7,006,542 | Added |
| Atlas Venture Life Science Advisors, LLC | $151M | 3.6% | 6,800,099 | Trimmed |
| Vanguard Capital Management LLC | $140M | 3.3% | 6,310,969 | Trimmed |
| TCG Crossover Management, LLC | $103M | 2.4% | 4,615,144 | Unchanged |
| Vanguard Portfolio Management LLC | $89.9M | 2.1% | 4,048,428 | Trimmed |
| Price T Rowe Associates Inc | $87.4M | 2.1% | 3,936,806 | Added |
| FCPM III Services B.v. | $85.5M | 2.0% | 3,848,256 | Trimmed |
| Geode Capital Management, LLC | $83.2M | 2.0% | 3,743,427 | Added |
| Vestal Point Capital, LP | $75.0M | 1.8% | 3,375,000 | Trimmed |
| Orbimed Advisors LLC | $71.9M | 1.7% | 3,235,684 | Added |
| Frazier Life Sciences Management, L.P. | $70.0M | 1.7% | 3,153,082 | Unchanged |
| Armistice Capital, LLC | $68.6M | 1.6% | 3,087,226 | Trimmed |
| JPMorgan Chase & Co | $67.2M | 1.7% | 3,151,656 | Trimmed |
| Perceptive Advisors LLC | $59.7M | 1.4% | 2,689,235 | Trimmed |
| Logos Global Management LP | $56.6M | 1.3% | 2,550,000 | Added |
| Bank of America Corp | $49.6M | 1.2% | 2,233,398 | Added |
| Venrock Adviser, LLC | $48.3M | 1.1% | 2,173,913 | Unchanged |
| Goldman Sachs Group Inc | $47.9M | 1.1% | 2,157,195 | Added |
| Siren, L.L.C. | $47.3M | 1.1% | 2,129,125 | Trimmed |
| Franklin Resources Inc | $45.1M | 1.1% | 2,030,819 | Added |
Share of 13F holdings is each fund's shares as a share of the 190,604,522 DYN shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- FMR LLC Added+$51.0M
- Price T Rowe Associates Inc Added+$35.7M
- Marshall Wace, LLP Added+$31.2M
- Logos Global Management LP Added+$25.5M
- Dimensional Fund Advisors LP Added+$22.1M
- Novo Holdings A/S New+$21.3M
- Citadel Advisors LLC Added+$20.9M
- State Street Corp Added+$17.9M
- Bank of America Corp Added+$17.5M
- BlackRock, Inc. Added+$15.6M
Biggest sellers in Q2 2026
- Atlas Venture Life Science Advisors, LLC Trimmed-$51.8M
- Perceptive Advisors LLC Trimmed-$44.0M
- Adage Capital Partners GP, L.l.c. Trimmed-$18.9M
- Stempoint Capital LP Sold out-$18.4M
- FCPM III Services B.v. Trimmed-$17.7M
- Braidwell LP Trimmed-$16.9M
- Vestal Point Capital, LP Trimmed-$13.9M
- Fiera Capital Corp Trimmed-$13.1M
- Squarepoint Ops LLC Trimmed-$11.9M
- Deep Track Capital, LP Trimmed-$11.1M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $390M and sold $295M; 88 added and 76 trimmed.
Schedule 13D and 13G filings on DYN
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-16WELLINGTON MANAGEMENT GROUP LLP SCHEDULE 13G filed by Dyne Therapeutics Inc.Schedule 13G
- 2026-05-06FMR LLC SCHEDULE 13G filed by Dyne Therapeutics Inc.Schedule 13G
- 2025-02-03Point72 Asset Management, L.P. SCHEDULE 13G filed by Dyne Therapeutics Inc.Schedule 13G
Questions about DYN ownership
- Who owns DYN stock?
- 246 institutional investment managers reported DYN positions in their Form 13F filings for Q2 2026, holding 190,604,522 shares worth $4.2B in total. T. Rowe Price Investment Management, Inc. reported the largest position.
- Are funds buying or selling DYN?
- In Q2 2026, 45 managers opened new DYN positions, 88 added, 76 trimmed and 29 sold out. Managers that filed in both quarters added a net 3,929,811 shares.
- How current is this DYN institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to DYN by CUSIP. Options are left out. DYN news and filings · DYN insider trades · Top funds